KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Exchange Rate Effect (2016 - 2025)

Merck (MRK) has disclosed Exchange Rate Effect for 17 consecutive years, with $23.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Exchange Rate Effect rose 106.27% to $23.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $563.0 million, a 292.15% increase, with the full-year FY2025 number at $563.0 million, up 292.15% from a year prior.
  • Exchange Rate Effect was $23.0 million for Q4 2025 at Merck, up from $10.0 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $374.0 million in Q2 2025 to a low of -$412.0 million in Q3 2022.
  • A 5-year average of -$12.5 million and a median of -$50.5 million in 2021 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 638.24% in 2022; the steepest drop was 795.65% in 2022.
  • Merck's Exchange Rate Effect stood at -$68.0 million in 2021, then soared by 638.24% to $366.0 million in 2022, then tumbled by 49.18% to $186.0 million in 2023, then tumbled by 297.31% to -$367.0 million in 2024, then surged by 106.27% to $23.0 million in 2025.
  • Per Business Quant, the three most recent readings for MRK's Exchange Rate Effect are $23.0 million (Q4 2025), $10.0 million (Q3 2025), and $374.0 million (Q2 2025).